| http://www.w3.org/ns/prov#value | - The thus obtained antibody which neutralizes the biological activity of Siglec-15 is useful as a pharmaceutical, particularly as a pharmaceutical composition for treating or preventing abnormal bone metabolism such as osteoporosis, bone destruction accompanying rheumatoid arthritis, or bone destruction accompanying cancer metastasis to bone, or as an antibody for immunological diagnosis of such a
|
